A Clinical Investigation on the Theragnostic Effect of MicroRNA Biomarkers for Survival Outcome in Cervical Cancer: A PRISMA-P Compliant Protocol for Systematic Review and Comprehensive Meta-Analysis

Peter Shaw, Raghul Senthilnathan, Srivarshini Sankar, Ilamathi Ilangovan, Gothandam Kodiveri Muthukaliannan, Siddhartha Baxi, Ravishankar Ram Mani, Mogana Rajagopal, Sasikala Chinnappan, Ashok Kumar Balaraman, Deepa Suresh, Sunil Krishnan, Madanmohan Gupta, Thangavel Muthusamy, Chitraabaanu Paranjothy, Rama Jayaraj

    Research output: Contribution to journalArticlepeer-review

    2 Downloads (Pure)

    Abstract

    Background: The most often diagnosed malignancy in women worldwide is cancer of the cervix. It is also the most prevalent kind of gynecological cancer in women. This cancer originates in the opening of the cervix and spreads through sexual contact. Even though human papillomavirus (HPV) may not cause cancer immediately, it does develop over time as a result of the virus’s lengthy persistence to cause dysplastic changes overtime, particularly in high-risk kinds. The primary objective of this research is to see if miRNAs are dysregulated as a result of treatment resistance in cervical cancer (CC). The aim is to see if these microRNAs may be utilized as biomarkers for detecting chemoresistance in CC, particularly for clinical applications. Methods: The recommended protocol for comprehensive study and meta-analysis (PRISMA-P) standards will be utilized for the analysis and data interpretation. The bibliographic databases will be methodically searched using a combination of search keywords. Based on established inclusion and exclusion criteria, the acquired findings will be reviewed, and data retrieved from the selected scientific papers for systematic review. We will then construct a forest from the pooled Hazard ratio (HR) and 95% CI values, data obtained using the random-effects model. Discussion: The focus of this study is to identify the function of miRNAs as a chemoresistance regulator and determine if they have the potential scope to be considered as biomarkers for cervical cancer. Through this systematic review and meta-analysis, the goal is to collect, compare, and analyze the data pertaining to the role of miRNAs in cervical cancer, thereby, enabling us to understand the role they play in chemosensitivity.

    Original languageEnglish
    Article number463
    Pages (from-to)1-11
    Number of pages11
    JournalGenes
    Volume13
    Issue number3
    DOIs
    Publication statusPublished - Mar 2022

    Fingerprint

    Dive into the research topics of 'A Clinical Investigation on the Theragnostic Effect of MicroRNA Biomarkers for Survival Outcome in Cervical Cancer: A PRISMA-P Compliant Protocol for Systematic Review and Comprehensive Meta-Analysis'. Together they form a unique fingerprint.

    Cite this